InsiderTrades.com logo

MDNA Insider Trading

Insider Ownership Percentage: 22.57%
Insider Buying (Last 12 Months): C$29,645.00
Insider Selling (Last 12 Months): C$0.00

Medicenna Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Medicenna Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medicenna Therapeutics Share Price & Price History

Current Price: C$1.56
Price Change: ▼ Price Decrease of -0.04 (-2.50%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for MDNA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Medicenna Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/13/2025Albert George BeraldoDirectorBuy500C$1.29C$645.00
1/9/2025David HymanSenior OfficerBuy20,000C$1.45C$29,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Medicenna Therapeutics (TSE:MDNA)

0.43% of Medicenna Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Medicenna Therapeutics logo
Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients.
Read More on Medicenna Therapeutics

Today's Range

Now: C$1.56
Low: C$1.50
High: C$1.68

50 Day Range

MA: C$1.27
Low: C$0.89
High: C$1.62

52 Week Range

Now: C$1.56
Low: C$0.78
High: C$2.16

Volume

239,812 shs

Average Volume

54,219 shs

Market Capitalization

C$130.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.829824

Who are the company insiders with the largest holdings of Medicenna Therapeutics?

Medicenna Therapeutics' top insider investors include:
  1. Albert George Beraldo (Director)
  2. David Hyman (Senior Officer)
Learn More about top insider investors at Medicenna Therapeutics.